Mendeleev Commun., 2006, 16(5), 245–247
Solid-state properties of 1,2-epoxy-3-(2-cyanophenoxy)propane,
a conglomerate-forming chiral drug precursor
Alexander A. Bredikhin,* Zemfira A. Bredikhina, Dmitry V. Zakharychev, Flyura S. Akhatova,
Dmitry B. Krivolapov and Igor A. Litvinov
A.E. Arbuzov Institute of Organic and Physical Chemistry, Kazan Scientific Centre of the Russian Academy of Sciences,
420088 Kazan, Russian Federation. Fax: +7 8432 73 2253; e-mail: baa@iopc.knc.ru
DOI: 10.1070/MC2006v016n05ABEH002388
Both enantiomers of 1,2-epoxy-3-(2-cyanophenoxy)propane 1a were obtained and converted into enantiomeric bunitrolol hydro-
chlorides 3 to confirm the configuration of the formers; racemic 1a undergoes spontaneous resolution upon crystallization and
could be resolved into individual enantiomers by a preferential crystallization with low efficiency.
Racemic arylglycidyl ethers 1 are customary intermediates in the
industrial production of racemic β-blocker drugs 2 (Scheme 1).
For (S)-1a, Nicola et al.6 reported a positive sign for specific
rotation in ethanol. Sayyed et al.8 also reported a positive sign
for specific rotation for the same enantiomer but in chloroform.
We found that epoxide 1a, as well as o-methoxy derivative 1b,
belongs to uncommon compounds changing the sign of rotation
with the change of solvent. The sample of (S)-1b with [a]D20 +13.0
(c 0.6, EtOH) manifests [a]D20 –4.9 (c 0.6, CHCl3). The sample
of 1a with [a]D20 +18.1 (c 1.0, EtOH) simultaneously demonstrates
[a]D20 –5.0 (c 1.0, CHCl3) or [a]D20 –14.5 (c 0.65, CCl4).
To establish the absolute configuration for 1a, we transformed
both enantiomers of the compound into β-blocker bunitrolol 3
(Scheme 2).‡
O
O
ArOH +
Cl
ArO
– HCl
1
NH2Alk
Alk
ArO
N
H
HO
H
2
Scheme 1
1,2-Epoxy-3-(2-cyanophenoxy)propane 1a has an obvious
structural similarity with and can be used as an intermediate in
the synthesis of β-adrenoblockers bunitrolol 3 and epanolol 4.1
Levorotary bunitrolol hydrochloride was obtained from dextro-
rotary (in ethanol) epoxide, as well as dextrorotary 3·HCl derives
†
Racemic 1a was prepared from racemic epichlorohydrin and 2-hydroxy-
benzonitrile by a known procedure,5 bp 120–122 °C at 0.05 Torr, mp 66–
67 °C (colourless needles from diethyl ether) [lit.,5 mp 65 °C (diethyl
ether)]. 1H NMR (400 MHz, CDCl3) d: 2.83 [dd, 1H, C(1)H2, 2J –4.8 Hz,
CN
CN
OH
O
O
O
NHBut
3J 2.7 Hz], 2.92 [dd, 1H, C(1)H2, J –4.8 Hz, J 4.2 Hz], 3.34–3.39 [m,
1H, C(2)H], 4.08 [dd, 1H, C(3)H2, 2J –11.6 Hz, 3J 5.4 Hz], 4.37 [dd, 1H,
C(3)H2, 2J –11.6 Hz, 3J 3.1 Hz], 6.99–7.02 [m, C(4A)H, C(6A)H], 7.44–
7.53 [m, C(3A)H, C(5A)H]. 13C NMR (100.6 MHz, CDCl3) d: 44.53
[C(1)], 49.89 [C(2)], 69.58 [C(3)], 102.45 [C(2A)], 112.89 [C(6A)],
116.29 [C(4N)], 121.49 [C(4A)], 133.88 [C(3A)], 134.47 [C(5A)], 160.22
[C(1A)].
2
3
1a
Bunitrolol, 3
OH
CN
OH
O
O
NH
N
H
(R)-1a was obtained from (S)-epichlorohydrin {[a]D20 +32.5 (c 4.3,
MeOH), op 98%; 5.5 g, 0.06 mol} and 2-hydroxybenzonitrile (2.4 g,
0.02 mol) by the same procedure as for the racemic compound.5 The
crude (R)-1a (3.1 g) was repeatedly crystallised from diethyl ether and a
mixture of diethyl ether and methanol to give colourless needles {1.4 g
(39%); mp 90–91 °C; [a]D20 –17.5 (c 0.8, EtOH), ee 98.0% by d.s.c.}
{lit.,6 [a]D25 –16 (c 1, EtOH)}.
Epanolol, 4
For the family of β-adrenoblockers and for bunitrolol parti-
cularly, it has been shown that (S)-enantiomers are eutomer com-
ponents of the racemic drug, whereas (R)-enantiomers (distomers)
usually display other (often undesirable) activity.2,3 Therefore,
interest in preparative procedures and the properties of scalemic
aryl glycidyl ethers as the precursors of single enantiomer drugs
is understandable. We have disclosed recently the conglomerate
nature of 1,2-epoxy-3-(2-methoxyphenoxy)propane 1b, another
valuable aryl glycidyl ether.4 Here, we consider the solid-state
properties, namely, IR spectra, thermal behaviour, and X-ray
structure of epoxide 1a, as well as some comments on the pos-
sibility of spontaneous resolution of racemic 1a.
Rac-, (R)- and (S)-1a have been prepared uniformly through
the reaction of rac-, (S)- and (R)-epichlorohydrin and 2-hydroxy-
benzonitrile.† Some comments must be done on the configura-
tion ascribing to scalemic 1a samples. We believe that, in our
case, the configuration of resulting epoxides 1a is predominantly
inverted as against the configuration of the starting epichloro-
hydrine as it has happened to be in a similar reaction with
guaiacol.4 Generally, C(3)-activated 1,2-epoxypropanes do not
react with nucleophiles in an unambiguous fashion: alongside
the normal attack on the C(3) atom occurs an attack on the C(1)
atom with the opening and subsequent closure of the oxirane
ring.7 The first direction is accompanied by conservation of
starting material configuration, whereas the other direction leads
to an opposite enantiomer as a product, and on the whole the
nucleophilic substitution with epichlorohydrine can lead to any
stereochemical results.
(S)-1a was synthesised analogously from (R)-epichlorohydrin. colour-
less needles; mp 90–91 °C (diethyl ether–methanol), [a]D20 +18.1 (c 1.0,
EtOH), [a]D20 –5.0 (c 1.0, CHCl3), ee 99.92% by d.s.c.; {lit.,6 mp 88–
89 °C, [a]D25 +17.69 (c 1, EtOH); lit.,8 gum, [a]D25 +2.3 (c 2.3, CHCl3)}.
The NMR spectra for both enantiomers coincide completely with the
spectra for rac-1a.
‡
(R)-(+)-1-(2-Cyanophenoxy)-3-tert-butylaminopropan-2-ol hydro-
chloride; (R)-bunitrolol hydrochloride; (R)-3·HCl. (R)-1a {0.76 g,
4.3 mmol, [a]D20 –17.0 (c 0.5, EtOH)} and 4.6 ml (43 mmol) of ButNH2
were heated under reflux for 5–7 h. The reaction was monitored by TLC.
After disappearance of the starting epoxide, the mixture was evaporated
to dryness and the residue was dissolved in diethyl ether; dry HCl was
passed through the solution until saturation. The solid hydrochloride
was filtered off (yield 87%); after two successive crystallizations from
EtOH (R)-3·HCl was isolated in 66% yield, mp 188–191 °C, [a]D20 +29.1
1
(c 0.9, EtOH). H NMR (600 MHz, CDCl3) d: 1.54 (s, 9H, Me), 3.29
(dd, 1H, CH2N, 2J –18.5 Hz, 3J 9.5 Hz), 3.40 (dd, 1H, CH2N, 2J –18.5 Hz,
2
3
3J 8.6 Hz), 4.25 (dd, 1H, CH2O, J –9.5 Hz, J 5.1 Hz), 4.29 (dd, 1H,
CH2O, 2J –9.5 Hz, 3J 4.0 Hz), 4.72 (m, 1H, CH), 5.50 (s, 1H, OH), 7.03–
7.06 [m, C(4A)H, C(6A)H], 7.53–7.56 [m, C(3A)H, C(5A)H], 8.29 (s,
1H, NH), 9.62 (s, 1H, NH). 13C NMR (150.864 MHz, CDCl3) d: 25.91
(Me), 45.28 (NCH2), 58.01 (CMe3), 65.58 (CHOH), 70.82 (OCH2), 102.36
[C(2A)], 113.04 [C(6A)], 116.27 (CN), 121.50 [C(4A)], 133.43 [C(3A)],
134.50 [C(5A)], 160.14 [C(1A)]. The numbering of atoms in the aromatic
part is shown in Figure 3.
(S)-3·HCl was obtained from (S)-1a and ButNH2 following the above
procedure; mp 188–191 °C, [a]D20 –29.2 (c 0.7, EtOH).
Mendeleev Commun. 2006 245